send mail to support@abhimanu.com mentioning your email id and mobileno registered with us! if details not recieved
Resend Opt after 60 Sec.
By Loging in you agree to Terms of Services and Privacy Policy
Claim your free MCQ
Please specify
Sorry for the inconvenience but we’re performing some maintenance at the moment. Website can be slow during this phase..
Please verify your mobile number
Login not allowed, Please logout from existing browser
Please update your name
Subscribe to Notifications
Stay updated with the latest Current affairs and other important updates regarding video Lectures, Test Schedules, live sessions etc..
Your Free user account at abhipedia has been created.
Remember, success is a journey, not a destination. Stay motivated and keep moving forward!
Refer & Earn
Enquire Now
My Abhipedia Earning
Kindly Login to view your earning
Support
Type your modal answer and submitt for approval
Write a precis of the passage given below in about one-third of its length. Please do not give any title to it. The precis should be written in your own language.
The round was co-led by the university’s commercialisation arm Cambridge Enterprise and global technology investor Amadeus Capital Partners – co-founded by Hermann Hauser – with participation from Sky media group’s impact investment fund Sky Ocean Ventures and the University of Cambridge Enterprise Fund VI, managed by Parkwalk. Xampla is developing the world’s first plant protein-based replacement for microplastics added to everyday items. The funding will enable the startup to develop its prototype material into products.
Its initial target is the $12 billion microencapsulation market in which manufacturers of home and personal care products currently rely on synthetic polymer capsules, a usage the EU is considering banning. Dr Elaine Loukes, Investment Director, Cambridge Enterprise, said: “Xampla has come up with a remarkable alternative to plastic. The fabrication process mimics those used by nature and the product is entirely made from natural materials. We are very pleased to be supporting a company with the potential for tremendous beneficial impact.”
Unlike current alternatives to microplastics, which are based on plant polysaccharides, such as cellulose and algae, Xampla’s plant protein materials do not rely on chemical cross-linking for their performance. This enables them to decompose quickly and completely in the natural environment. Amelia Armour, Principal, Amadeus Capital Partners, said: “Xampla is a great example of deep tech emerging from the UK research base at exactly the right time to respond to regulatory changes and consumer trends around plastic. “We’re excited to be investing alongside an impact investor and backing a world-class science team that can offer commercial solutions for multiple industries.”In proposing regulations on added microplastics, the European Chemicals Agency (ECHA) found that each year in Europe added microplastics equivalent to 10 billion plastic bottles were released into the environment and were practically impossible to remove.
By: bhavesh kumar singh ProfileResourcesReport error
Access to prime resources
New Courses